Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Navitoclax-piperazine (ABT-263-piperazine) is an inhibitor of B-cell lymphoma extra large (BCL-XL).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 158.00 | |
5 mg | In stock | $ 324.00 | |
10 mg | In stock | $ 550.00 | |
25 mg | In stock | $ 868.00 | |
50 mg | In stock | $ 1,190.00 | |
100 mg | In stock | $ 1,610.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 560.00 |
Description | Navitoclax-piperazine (ABT-263-piperazine) is an inhibitor of B-cell lymphoma extra large (BCL-XL). |
Synonyms | ABT-263-piperazine |
Molecular Weight | 973.63 |
Formula | C47H56ClF3N6O5S3 |
CAS No. | 2143096-93-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 250 mg/mL (256.77 mM), Sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Navitoclax-piperazine 2143096-93-7 Apoptosis PROTAC BCL Ligands for Target Protein for PROTAC Navitoclaxpiperazine Bcl-2 Family B-cell VHL Target Protein-binding Moiety inhibit Inhibitor lymphoma ubiquitin ABT-263-piperazine ligase Navitoclax piperazine inhibitor